It has been shown that MYPT1 is a regulatory subunit of the PP1A enzyme, which targets NF2, whose dephosphorylation at serine 518 is the initial step in the Hippo pathway, resulting in growth arrest and tumor suppression [29, 30]. This evidence concerns the gene PPP1CA and neoplasm.